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1. Introduction 
In today’s world, human immunodeficiency virus (HIV)/acquired immunodeficiency 
syndrome (AIDS) has poorly affected the vast majority of population and has been declared 
as one of the worst pandemic. It still remains the major public health burden across the 
world. The burden of HIV is increasingly progressing and due to lack of adequate 
knowledge among the population, their management is severely compromised. 
Advancement in the treatment of these cases are significant. New treatments are capable of 
reducing plasma viral load and in turn decreasing mortality (Carpenter et al., 1998). The 
betterment of patients with existing treatment regimen is quite evident, at least clinically 
and virologically. Here, important question is regarding life threatening impact of virus on 
various vital functions of the body. That includes central and peripheral nervous system 
(CNS) function. Such impact of virus becomes more evident, once their number increases to 
a numeric mark most often at the later stage of infection. However, it is reported that HIV 
enters the CNS within two weeks of initial infection (Krebs et al., 2000). Neuropsychological 
compromise are thought to occur secondary to HIV infection (Becker et al., 1997; Bornstein 
et al., 1993; Grant & A. Martin, 1994; Heaton et al., 1995; Hinkin et al., 1995; Maj et al., 1994a; 
Maj et al., 1994b; Martin et al., 1992; Stern, 1991; Van Gorp et al., 1989; von Giesen et al., 
2001). When cases are presented, HIV-related neurocognitive disfunctioning may remain 
unnoticed at very early stage of infection. As the disease progress from asymptomatic to 
symptomatic and then to full blown AIDS, many neuropsychological impairments of clinical 
relevance appears in daily life of the patient, which may or may not have any functional 
significance. Especially, individual infected with HIV who is otherwise physically 
asymptomatic, these deficits may result in significant morbidity, in the sense that infected 
people may be unable to perform important tasks (e.g. bathing, cleaning, driving, work 
tasks), that influence their quality of life (QOL) and healthcare management directly. Such 
impairments may range from less severe unnoticeable defects to frank dementia syndromes 
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that profoundly disrupt an infected individual’s functioning and activities of daily living. 
The neurocognitive deficits typically associated with HIV-1 infection include decrements in 
motor and information-processing speed, divided attention, memory retrieval processes, 
and executive functioning. Overall, the gross estimates of people infected HIV who 
experience neuropsychological impairment is range from 30% to 50% of total infected 
individuals (Grant & Martin, 1994; Foley et al., 2008).  
Neuropsychological impairment can be classified into three subgroups (Grant et at., 1988). 
First group includes patients with subsyndromic neuropsychological impairment show 
deficits in at least two neuropsychological domains with no evidence of functional 
impairment. Second group is mild neurocognitive disorder or minor cognitive/ motor 
disorder and involve deficits in at least two domains (of ability) of neuropsychological test 
battery, sufficient affect patient daily functioning. Third group consist of most severe HIV-1 
associated dementia which is characterized by moderate to severe cognitive and 
psychomotor slowing, impaired concentration and attention, memory disturbances and 
often motor incordination and weakness. Many studies made attempt to found factors 
associated with neurocognitive impairment in HIV infection. However, factors related to 
neuropsychological impairment remain poorly understood. Herewith, we have reviewed 
the possible factors and divided them into three groups depending on their origin. Present 
chapter is an attempt to review the available literature on the possible factors and to discuss 
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Fig. 1. Factors affecting HIV associated neuro-cognitive impairment  
HIV associated neuro-cognitive impairment /disorder are affected by three confounding 
factors; Biological factors, Psychological factors, Environmental and demographic factors. 
Initially, HIV does not easily get into the brain. But once it enters through blood-brain 
barrier and infects the resident microglial cells (a type of macrophage, which harbours the 
virus). Majority of the influence of biological factors are mediated by direct infection of HIV 
in brain. Symptoms of HIV associated neuro-cognitive impairments are misjudged with 
various other psychological problems like depression/ mood disorder, apathy and stress. 
Environmental and demographic factors like age, gender etc. also influence the HIV 
mediated neuro-cognitive impairment.    
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2. Biological factors 
2.1 Direct infection of HIV 
Earlier, for long time, it was never thought of that HIV can also infect brain cells and that led 
to poor interpretation of many mental disorders associated with HIV-1 infection. Now, this 
biological stigma has been resolved. HIV-1 targets the cells of lymphoid and myeloid origin 
containing major HIV-1 receptors, CD4 and various chemokine receptors considered as 
HIV-1 co-receptors. These receptors help the attachment of the virus to the cell and the 
fusion of their membrane resulting in the entry of the virus into the cell (Zaitseva et al., 
2003). Infected CD4+ T cells and monocytes, which circulate in the blood, are the potential 
source of CNS infection (Gonzalez-Scarano & Martin-Garcia, 2005). Many cells, such as T 
cells and monocytes are infected by HIV-1, these cells circulate in the blood and can cross 
the blood-brain barrier (BBB) and propagate the infection within the CNS (Figure-2) (Haase, 
1986). A major part of HIV-1 associated neurological disfunctioning may be attributed to the 
entry of HIV-1 into the brain by crossing. The HIV-1 associated neuropathology is 
characterized by the infiltration of HIV-1 carrying macrophages into the CNS; the formation 
of microglial nodules; and multinucleated giant cells which result possibly from virus-
induced fusion of microglia and/or macrophages in central white and deep gray matter; 
activation of astrocytes and their damage; neuronal loss particularly in hippocampus, basal 
ganglia and caudate nucleus. In addition, a variable degree of white matter pathology with 
evidence of broad range of myelin damage has been reported. HIV-1 has also been detected 
in the cerebral spinal fluid (CSF) (Gendelman et al., 1994). Imaging of brain using MRI, 
confirm that HIV infection is associated with progressive cortical atrophy within the gray 
and white matter, particularly in the later stage of the disease (Hall et al., 1996; Dal Pan et 
al., 1992; Stout et al., 1998; Aylward et al., 1993). These studies confirm that in the latter stage 
of infection, the anatomical atrophy in certain parts of brain occurs and many of them 
proven critical in the daily functioning of the individuals. These studies also report a 
correlation between the deterioration of cognitive function and the reduction in volume of 
certain brain structures. 
2.2 Immunodeficiency (opportunistic infections, CD4 & plasma viral load) 
2.2.1 Level of plasma HIV ribonucleic acid (RNA)  
The levels of HIV-1 or its immune-dominant antigens/RNA (viral load) in plasma of 
infected individuals are the established marker for onset/progress of HIV related pathology. 
Infection of HIV-1 to brain cells is characterized by their presence in CSF. It is also proven 
that level of HIV RNA in CSF is elevated in subjects with cognitive impairments (Ellis et al., 
1997; McArthur et al., 1997) and it also predicts future neuropsychological impairment (Ellis 
et al., 2002).The relationship between viral load and the mechanisms of cognitive decline 
requires further study. Clinically, however, a relationship between plasma HIV RNA levels 
and cognitive impairment would be more useful for diagnostic point of view. It is 
postulated that higher plasma HIV RNA levels may be associated with higher levels of 
circulating HIV-infected monocytes which may enter the blood-brain barrier and affect CNS 
functioning (Gartner, 2000). However, research on the direct relationship between plasma 
viral load and cognitive functioning remains equivocal. Various group failed to find a 
relationship between overall impairment and plasma HIV RNA (Ellis et al. 1997; Reger et al., 
2005). However, contradictory reports are also available (Childs et al., 1999; Ellis et al., 2002). 
In a small neuropsychological battery, Stankoff et al. (1999) found a significant relationship 
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between motor functioning and plasma viral load. It seems that plasma viral load is 
associated with neuropsychological impairment but a lot is required to confirm its role as a 
predictive marker for neuropsychological impairment. Contradictory reports suggest that a 
comprehensive, in-depth and longitudinal approach with a multi-domain tool is needed is 
required to affirm its role as a marker. 
2.2.2 Opportunistic infections 
Opportunistic infections (OIs) of HIV patients significantly reduce their immunity to HIV 
and this majorly compromised their QOL. OIs generally occur in HIV infected patients with 
CD4 below 200, when their immune system is not sufficient enough to mount required 
immunity to prevent the OIs. Development of OIs further compromises their immunity, 
which in turn aggravates the expansion of HIV-1 and it’s spillage into CNS. It is also seen 
that presence of OIs in HIV infected patients are significantly associated with 
neuropsychological impairment in HIV infection. The determination of causes of 
neuropsychological impairment in HIV infection becomes more difficult because of various 
co-infections associated with it. More often heavy and chronic use of neuro-toxic drugs 
make it more complicated to study about exact cause. While challenging, these are questions 
that at one time in the HIV pandemic seemed difficult to imagine. 
2.2.3 Treatment of disease  
The effects of the HAART on neurocognitive functioning have not been assessed, although 
there have been some scanty studies showing neurocognitive effects of zidovudine (AZT) 
(Schmitt et al., 1988;  Sidtis et al. 1993; Martin et al., 1999). Because drugs (HAART) can cross 
blood-brain barrier to achieve sufficient concentration to inhibit HIV replication in the CNS 
(Enting et al, 1998; Tashima, 1998; Limoges et al., 2000). It has also been shown that 
Zidovudine (AZT) monotherapy at current standard and higher doses can improve 
neuropsychological performance (Schmitt et al., 1988, Martin et al., 1999) and severity of 
dementia (Sidtis et al., 1993). However, the benefits of AZT monotherapy may be temporary 
because of the emergence of viral resistance (Gulevich et al., 1993). It was observed that 
individuals who are treated with HAART shortly after the first symptoms of dementia 
appear may show dramatic improvement. 
2.2.4 CD4 
Several studies reported that CD4 count is negatively related with neuropsychological 
impairment. Bornstein et al., (1991) found that patients with CD4 levels less than 200 had 
low scores on measures of motor speed, verbal memory acquisition, visual motor speed and 
mental  tracking in comparison to patients with CD4 counts above 200. Osowiecki, et al. 
(2000) has reported a significant association of CD4 count with neurocognitive deficits. 
Perry, et al. (1989) found that among HIV positive patients, those scoring in the impaired 
range on neuropsychological measures had lower CD4 counts and lower CD4 /CD8 ratios 
than patients scoring in the normal range. It is also suggested that CD4 level correlates 
significantly with cognitive functioning. Several other studies have reported no relationship 
between neuropsychological performance and CD4 cell count (McArthur et al., 1989; Saykin 
et al., 1988; Martin et al., 1998). According to Honni and Bornstein (2002) there is very little 
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Fig. 2. HIV crosses blood-brain barrier (BBB) 
Infected macrophages (carrying HIV) crosses the blood brain barrier and enters into the 
brain and infects other cells. Infected cells as well as other resident brain cells produce 
copious amount of mediators (inflammatory factors, various neurotransmitter etc. In the 
presence of HIV, these factors irreversibly damage the astrocytes and neurons.  
3. Psychological factors 
3.1 Depression 
Neuropsychological impairments are common in HIV infection with major depression 
although their nature remains partly unclear. Hypothalamic-pituitary-adrenal axis 
dysfunction is associated with neuropsychological dysfunction in major depressive disorder 
although evidence of direct causation is not definitive at present. Appearance of symptoms 
of depression has been significantly reported in patients with HIV-1 infection (Atkinson, et 
al., 1988; Perry., 1990; Perkins et al., 1994; Rabkin, 2000). However, the causative co-existence 
of major depression and neuropsychological impairment has not been reported. 
Additionally, symptoms of depression and neuropsychological impairment may occur 
together in many HIV-infected persons. Cysique et al., (2007) reported that neurocognitive 
impairment and major depression should be considered as two independent processes. 
Moreover, studies have demonstrated that neuropsychological abnormalities observed in 
HIV infection are distinct and cannot be attributed to depression (Marsh et al., 1994; Mapou 
et al., 1993; Perkins et al., 1994; Richardson et al., 1999; Bornstein et al., 1993, Claypoole et al., 
1998; Goodwin et al., 1996; Goggin et al., 1997; Grant et al 1988; Moore et al., 1997). It has 
been shown that depressed patients with HIV-1 infection may exhibit deficits in learning 
and memory (Claypoole et al., 1998; Goggin et al., 1997; Kalechstein et al. 1998), but the 
contributions/involvement of depression to the impairment and severity of the 
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neuropsychological functioning appear to be minimal. However, more research is needed to 
confirm and widen these findings, and to expand the knowledge into clinical practice. 
3.2 Apathy 
Apathy refers to a cluster of symptoms reflecting lack of motivation manifested in motoric, 
emotional, and cognitive domains. To define here, motoric apathy is characterized by the 
tendency not to initiate a new motor activity unless externally prompted. Emotional apathy 
is defined as diminished intensity or persistence of emotion, or placidity, relative to the 
importance of some goal-directed thought or event. The third one, cognitive apathy is 
defined as indifference, a generalized loss of interest, decrease in goal-directed thought 
content diminished motivation associated with executive functions, and sometimes 
decreased verbal fluency. In context to the subject, Castellon et al., (1998) investigated the 
relationship between apathy, depression, and cognitive performance in HIV infection. They 
reported that apathy, but not depression, was found to be associated with working memory 
deficits among HIV subjects. Higher apathy scores and poorer working memory 
characterized the subjects with AIDS. Castellon et al., (1998) concluded that apathy is 
independent of depression and may indicate CNS involvement in HIV infection. In contrast, 
Rabkin et al., (2000) reported that apathy was consistently related to depression and 
unrelated to neuropsychological impairment. 
3.3 Stress 
Life stress has frequently been examined in the context of psychosocial factors in HIV-
infected people because of the known adverse effects of stress on immunity of host 
(Patterson et al., 1995; Evans et al., 1997). In the context of cognitive function among HIV-
infected people, the potential importance of stress has gained increased support from 
available literature. Moreover, these reports have demonstrated its adverse effects on brain 
structure and function. Several animal studies have reported atrophy in the CA3 region of 
the hippocampus in response to stress (Kim & Yoon, 1998). The chronic stress induced 
structural changes in brain is mediated by glucocorticoid hormones and neurotransmitters 
such as serotonin and the GABA-benzodiazepine system (McEwen, 2000) Furthermore, 
corticosterone a glucocorticoid appears to regulate levels of internal calcium (Ca2+) and 
thus may influence synaptic plasticity, aging, and cell death (Kim & Yoon, 1998). In context 
to patients, It has been demonstrated that atrophy in brain and abnormalities in its function 
are result of heightened levels of glucocorticoids and severe, traumatic stress (McEwen, 
2000). In another study, it is observed that stressful life events were significantly related to 
cognitive performance only in the HIV-infected subjects (Pukay-Martin et al., 2003). 
3.4 Drug addiction  
It is well known that the intravenous administration of drugs with shared needles is an 
important cause for the spread of HIV burden. The persistent use of drugs through other 
routes (e.g., inhaling crack/cocaine) may also increase the risk for HIV infection. Drug 
abusers also practice prostitution to support their livelihood, habit and they may also 
engage in risky sexual behavior while under the influence of drugs or alcohol. But injection 
drug use with shared needle has also been seen as a main reason for the rapid progression 
of HIV among drug abusers (Bouwman et al., 1998), and has been found to diminish overall 
neuropsychological performance and reduce visuomotor processing, executive functioning, 
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motor speed and strength, and sensorimotor perception in persons in the very early stages 
of HIV infection (Claypoole et al., 1993). It was initially thought that frequent drug usage  
may impair the cognitive functioning among HIV-seropositive persons for (Wellman, 1992). 
It was also postulated that drug usage possibly induces CNS impairment independent of 
that caused by HIV infection. However, this argument does not appear to hold true, asmost 
studies have found that neuropsychological dysfunction may not be contributed solely or 
partially by substance abuse, if we do not consider HIV seropositivity (Janssen et al., 1989). 
It was also suggested that the interaction of HIV infection and drug use might produce 
additive and synergistic cognitive deficits. Studies suggest that co-presence of HIV infection 
and drug use does not affect the cognitive functioning (Selnes et al., 1990; Selnes et al., 1992; 
Goodwin et al., 1996; Bornstein et al., 1993; Bono et al., 1996; Selnes et al., 1995). Cristiani et 
al., (2004) reported that the effect of marijuana use was greatest in subjects with 
symptomatic HIV infection. Further inspection suggested that this effect was due primarily 
to performance on memory tasks. Their finding  suggest that although there is minimal 
impact of marijuana on uninfected individuals or those at early stages of HIV infection, 
there is a synergistic effect of HIV and marijuana use in patients with advanced HIV disease. 
Exception to the earlier studies, it was reported that HIV infection and methamphetamine 
dependence are each associated with neuropsychological deficits, and suggest that these 
factors in combination are associated with additive deleterious cognitive effects (Rippeth et 
al., 2004). It is also suggestive of that both HIV infection and methamphetamine dependence 
can be associated with brain dysfunction. 
4. Environmental and demographic factor 
4.1 Education 
A certain level of education is required for the prevention and cure of HIV infection. It is 
now established that low education level is an independent risk factor for HIV-1 related 
cognitive impairment. Stern et al., (1996), Maj et al., (1994), Satz et al., (1993) reported that 
low educational level (6 years) increases the risk of HIV-1–related cognitive impairment in 
HIV-1–seropositive persons (asymptomatic and symptomatic). Our own unpublished data 
is in concordance with their findings. It is important to note that the association between 
low educational level and HIV-1–related cognitive impairment was independent of all other 
putative risk factors. In addition to this, another study also suggests that discrepancy in 
reading and education level is associated with worse neuropsychological performance 
(Ryan et al., 2005). There are two possible variables related to literacy, those are frequently 
used to predict the neuropsychological functioning; reading ability and years of education. 
In a country like India and particularly in its remote rural areas, it is difficult to predict the 
total year(s) of education. In such situations, it is better to rely on the reading ability of an 
individual. In other parts of world, previous research has also shown that reading ability is a 
stronger predictor of cognitive functioning than year(s) of education. Dotson et al., (2009) 
reported that reading ability predicts cognitive functioning than year(s) of education. They 
also suggest that influence of literacy and year(s) of education on cognitive functioning may 
vary among individuals belong to certain racial minority status and low SES group.  
4.2 Age 
The impact of age on some aspects of neuropsychological performance is well established. 
In addition, data indicate that age at the time of seroconversion is significantly associated 
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with HIV disease progression and survival time (Babiker et al., 2001). The possibility of an 
interaction between age and disease level on cognitive function has not been explored 
thoroughly. Both age and HIV status have been established as independent risk factors for 
the development of cognitive impairment, it is both reasonable and important to question 
whether the interaction of these two factors may constitute increased risk of impairment in 
HIV-infected individuals. While several studies have explored the impact of age on 
cognitive function in HIV infected subjects (Janssen et al., 1992; McArthur et al., 1993; Kim et 
al., 2001; Pereda et al., 2000) few have examined the interaction of age and disease status 
(Van Gorp et al., 1994; Hardy et al., 1999). Kissel et al., (2005) reported that Age and disease 
status had independent effects on cognitive function, but there were no significant 
interactions either on a summary measure of performance or on individual test scores. 
4.3 Gender 
Chiesi  et al. and the AIDS in Europe Study Group (1996) reported that rates of cognitive 
impairment were higher for women. The hypothesis that female seropositive subjects are 
more vulnerable for neuropsychological impairment than seropositive men, is explained by 
Satz et al. (1993) that they usually have an extensive pre-morbid history, a history of 
substance abuse, a lower economic level, a greater psychiatric morbidity and a low 
educational level (Ickovics & Rodin, 1992;  Melnick et al., 1994) variables that could increase 
the risk of neuropsychological impairment associated with HIV-1 (Stern et al., 1996). Faílde-
Garrido et al. (2008) reported different neuropsychological impairment pattern was detected 
between genders: while HIV+ men had greater impairment in visual memory, attention, 
psychomotor speed and abstract reasoning, HIV+ women had greater impairment on 
attention, psychomotor speed and verbal memory for texts. They further reported that there 
is no difference between the neuropsychological performance of seropositive male and 





































Fig. 3. Figure showing interrelationship among HIV infection, immunity of the host, 
neuropsychological functioning and quality of life (QOL) 
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HIV infection, immunity of the host, neuropsychological functioning and QOL are 
interlinked and affects each other. Various factors may influence neuropsychological 
functioning and immunity of the host. (-) and (+) sign shows negative association 
respectively. → and ↔ depicts uni and bidirectional interaction between two. 
5. Conclusion 
In conclusion, much can learn about factors associated with neuropsychological impairment, 
a leading cause of morbidity and mortality in persons with HIV infection. It was the intent 
of this manuscript not only to summarize what we know about factors associated with 
neuropsychological impairment  in HIV infection but also to point out what we don't know 
and to highlight future directions that this area of research must now address. The adverse 
effect of HIV on neuropsychological functioning is well established. Manifestations of 
neurocognitive dysfunction range from subtle and mild cognitive changes to frank dementia 
syndromes. We have primarily focused on the factors associated with neuropsychological 
impairment, which is adversely affect QOL and patients' ability demanding daily activities 
(Figure-3). There are very few studies focusing on factors associated with 
neuropsychological impairment in HIV infection. This review categorized factors into three 
broad areas that significantly associated with neuropsychological impairment. There are 
lacks of consensus among available literature regarding factors associated with 
neuropsychological impairment in HIV infection, especially psychological and 
environmental/demographic factors. Contradictory finding have been reported regarding 
association between neuropsychological impairment and antiretroviral therapy, drug abuse, 
depression, apathy, stress, age, gender and education. This review help the health care 
professionals in proper care of HIV seropositive  people those are at risk to develop 
cognitive impairment. Present chapter also mentions the fact that tertiary prevention is 
urgently needed to improve quality of life of HIV infected people. Comprehensive study is 
needed to explore the above relationship and is clearly an important area of investigations.  
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